BMRN vs FA · P/E 40, rev $2.85B vs P/E 318, rev $860.2M
Biomarin Pharmaceutical Inc (BMRN) versus First Advantage Corp (FA) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
First Advantage Corp (FA) is a specialty business services company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported FA revenue for 2024-12-31 was $860.2M. Net income was -$110.3M. Revenue was up 12.6% from 2023-12-31 to 2024-12-31. FA currently screens at market cap $2.72B and trailing P/E 317.6.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. FA currently screens at market cap $2.72B and trailing P/E 317.6.
Not investment advice. Open the BMRN and FA stock pages for the full models.
Not investment advice.